Oncolytics Biotech (ONCY) Reports Q2 Loss of $0.13/sh

Oncolytics Biotech (NASDAQ: ONCY) reported Q2 EPS of ($0.13), versus ($0.17) reported last year.

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• Oncolytics Biotech (ONCY) PT Lowered to $5 at H.C. Wainwright
• Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
• LSI Industries (LYTS) Tops Q4 EPS by 3c, Beats on Revenue